Search - tctmd.com

Displaying 141 - 160 of 963

Sort: Relevancy | Date

Presentation TCT 2017

Opening Address: Lesion Preparation Is the Most Underappreciated But Essential Component of Optimal PCI for Metallic DES and BRS

Presenter: Salvatore Brugaletta, Philippe Genereux, Nick E. J. West

November 01, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

Presentation TCT 2017

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

Presenter: Robert A. Harrington, Gregg W. Stone, Harry Suryapranata

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Presentation TCT 2017

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

Presenter: Robert A. Harrington, Gregg W. Stone, Elvin Kedhi

November 01, 2017

Presentation TCT 2017

Cre8: Novel Attributes and Clinical Trial Program Update

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Alaide Chieffo

November 01, 2017

Presentation TCT 2017

Yukon and Coroflex ISAR Polymer-Free DES: Clinical Outcomes and Future Directions

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Robert A. Byrne

November 01, 2017

Presentation TCT 2017

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

Presenter: Robert A. Harrington, Gregg W. Stone, Olivier Varenne

November 01, 2017

Presentation TCT 2017

BioFreedom: LEADERS FREE Long-term Results and LEADERS FREE II Design

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Philip M. Urban

November 01, 2017

Presentation TCT 2017

Polymer-Free Drug-Filled Stent and Updated REVELUTION Results

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Stephen G. Worthley

November 01, 2017

Presentation TCT 2017

Defining the High Bleeding Risk Patient: Consensus and Knowledge Gaps

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Marie-Claude Morice

November 01, 2017

Presentation TCT 2017

Saudi Arabia Presents: A Complex BVS Case

Presenter: Waqar H. Ahmed, Oscar A. Mendiz, Mohammed I Kurdi

November 01, 2017

Presentation TCT 2017

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Renu Virmani

November 01, 2017

Presentation TCT 2017

Local Liquid Paclitaxel Delivery Via a Novel Perfusion Catheter: Early Experimental and Clinical Results

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Saami K Yazdani

November 01, 2017

Presentation TCT 2017

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Costantino Del Giudice

November 01, 2017

Presentation TCT 2017

Statistical Comparison of the DANCE Trial 12-Month Outcomes of Adventitial Dexamethasone versus Comparator Drug-Coated Balloon Studies

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh

November 01, 2017

Presentation TCT 2017

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Piotr P. Buszman

November 01, 2017

Presentation TCT 2017

ENDURANCE of MOMENTUM: Destination Therapy State-of-the-Art

Presenter: Ulrich P. Jorde

November 01, 2017

Presentation TCT 2017

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Georgios Bouras

November 01, 2017

Presentation TCT 2017

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Pieter R. Stella

November 01, 2017

Advertisement

Opening Address: Lesion Preparation Is the Most Underappreciated But Essential Component of Optimal PCI for Metallic DES and BRS

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

Live From Denver: TCT 2017, Day Three

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

Cre8: Novel Attributes and Clinical Trial Program Update

Yukon and Coroflex ISAR Polymer-Free DES: Clinical Outcomes and Future Directions

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

BioFreedom: LEADERS FREE Long-term Results and LEADERS FREE II Design

Polymer-Free Drug-Filled Stent and Updated REVELUTION Results

Defining the High Bleeding Risk Patient: Consensus and Knowledge Gaps

Saudi Arabia Presents: A Complex BVS Case

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

Local Liquid Paclitaxel Delivery Via a Novel Perfusion Catheter: Early Experimental and Clinical Results

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Statistical Comparison of the DANCE Trial 12-Month Outcomes of Adventitial Dexamethasone versus Comparator Drug-Coated Balloon Studies

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

ENDURANCE of MOMENTUM: Destination Therapy State-of-the-Art

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content